The Greek Pharmacy: a Strategic Priority for ELPEN

The Greek Pharmacy: a Strategic Priority for ELPEN

24 October 2014

In its 50 years of operation, ELPEN has sought to develop strong bonds with Greek pharmacies based on a mutual cooperation and trust, thus acknowledging their significant contribution in providing high-standard scientific services to Greek patients. Following relevant meetings that were successfully carried out in Athens and Thessaloniki, with the participation of more than 1,000 pharmacists in total, ELPEN organized an information event at Chania, Crete, on Wednesday, October 22, 2014.

Read more
ELPEN's Vice President and PEF President, Mr. Theodore Tryfon, Inaugurates the Social Pharmacy of the Archdiocese of Athens

ELPEN's Vice President and PEF President, Mr. Theodore Tryfon, Inaugurates the Social Pharmacy of the Archdiocese of Athens

16 October 2014

ELPEN's Vice President and the newly elected President of the Panhellenic Union of Pharmaceutical Industries (PEF), Mr. Theodore Tryfon, together with the Archbishop of Athens and Greece, Ieronymos II, inaugurated the Central Social Pharmacy of the General Charity Fund of the Archdiocese of Athens, on Wednesday, October 15, 2014.

Read more

 Mr. Theodore Tryfon at the helm of the Panhellenic Union of Pharmaceutical Industries

Mr. Theodore Tryfon at the helm of the Panhellenic Union of Pharmaceutical Industries

30 September 2014

The Presidency of the Panhellenic Union of Pharmaceutical Industries (PEF) was won in the recent elections, by the union's former Vice President, Mr. Theodore Tryfon. At a time when supporting the Greek pharmaceutical industry has become increasingly imperative, emphasis placed on manufacturing, extroversion, as well as innovation, comprise the axes which will allow for the Healthcare sector to reach great heights. The Greek pharmaceutical industry has in fact been recognized as a critical driving force which will significantly contribute to the restructuring of the actual economy, and stimulate entrepreneurship.

Read more
ELPEN - Standing by Greek Pharmacists for the past 50 years

ELPEN - Standing by Greek Pharmacists for the past 50 years

19 September 2014

ELPEN recognizes the Greek pharmacy as a key generator of entrepreneurship, as well as an important link to health professionals. In this context, the company has expressed its unreserved support, by means of networking events with Greek pharmacists. After having successfully organized such events in Athens with more than 700 participant pharmacists, ELPEN also held an awareness event in Thessaloniki, on Monday, September 15, 2014.

Read more

ELPEN wins the Athens Chamber of Commerce and Industry (ACCI) R&D Award

ELPEN wins the Athens Chamber of Commerce and Industry (ACCI) R&D Award

26 June 2014

On June 23, 2014 ELPEN was awarded for the second time since 2005 with the "Research & Technological Development" award, by the Athens Chamber of Commerce and Industry (ACCI). This specific award comprises the third distinction within a month for ELPEN. It follows the award given to the company on May 22nd with the award regarding "Employment Growth", which award is given in the context ofthe Business Excellence Awards for "The Most Admired Enterprises". On June 13th, the Chairman, CEO of ELPEN, Mr. Dimitrios Pentafragas, was presented with the award by the Greek Society of Pharmacology and Clinical Pharmacology, at the Research Center of the Athens Academy.

Read more
Dimitrios Pentafragas, Founder and Chairman of ELPEN Pharmaceutical Co. Inc. is awarded for his substantial contribution to pharmaceutical research in Greece

Dimitrios Pentafragas, Founder and Chairman of ELPEN Pharmaceutical Co. Inc. is awarded for his substantial contribution to pharmaceutical research in Greece

13 June 2014

An important and moving awards ceremony took place at the Athens Academy Research Center, where the Founder and Chairman of ELPEN Pharmaceutical Co. Inc. was awarded by the Greek Association of Pharmacology and Clinical Pharmacology. The award honored Mr. D. Pentafragas's substantial contribution and long-standing commitment to clinical research aswell as his pioneering support and encouragement to researchers, nationally and internationally, by establishing the ELPEN Experimental and Research Center which focuses on scientific research and innovation in the pharmaceutical field.

Read more

20 May 2014

Read more

14 May 2014

Read more

"Stop experimenting with drug prices", as was stated by Mr. Theodore Tryfon

14 November 2013

A profound appeal to stop experimenting with drug prices was made by the Vice President of the Panhellenic Association of Pharmaceutical Industries (PEF) Mr. Theodore Tryfon, to the leadership of the Greek Ministry of Health on Wednesday, November 13, at a Stat Bank event entitled "Health-Drugs-Beauty 2013".

Read more

"Greek pharmaceutical companies adhere strictly to international standards", states Professor Machairas

11 November 2013

The fact that the Greek Pharmaceutical Industry meets high production standards was highlighted by Professor Panagiotis Machairas, Biopharmaceutics & Pharmacokinetics, National & Kapodistrian University of Athens, in his speech at the 1st Greek National Conference on "Crisis Management in Healthcare".

Read more

Pharmaceutical expenditure cutbacks pose a great health risk to patients, as stated by leading representatives of the Greek Pharmaceutical sector

Pharmaceutical expenditure cutbacks pose a great health risk to patients, as stated by leading representatives of the Greek Pharmaceutical sector

09 November 2013

An appeal to increase pharmaceutical expenditure in order to ensure the patients's access to reliable and qualitative treatments was made by the leaders of the Pharma sector on Saturday, November 9, at the 1st Greek National Conference on "Crisis Management in the Pharmaceutical Sector".

Read more
ELPEN's strategic global expansion spearheaded by the ground-breaking device: Elpenhaler<sup>®</sup>

ELPEN's strategic global expansion spearheaded by the ground-breaking device: Elpenhaler®

31 October 2013

ELPEN drugs are exported to 60 countries worldwide, 27 of which are in Europe, with the primary aim to achieve further global expansion, spearheaded by Elpenhaler®, an original product, patented by the company's founder, Mr. Dimitrios Pentafragas.

Read more